162 related articles for article (PubMed ID: 9283634)
1. Role of endothelium in angiotensin II formation by the rat aorta and mesenteric arterial bed.
Leite R; Esteväo R; Resende AC; Salgado MC
Braz J Med Biol Res; 1997 May; 30(5):649-56. PubMed ID: 9283634
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.
Zerrouk A; Auguet M; Delaflotte S; Chabrier PE
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):466-73. PubMed ID: 8897450
[TBL] [Abstract][Full Text] [Related]
3. Role of elastase-2 as an angiotensin II-forming enzyme in rat carotid artery.
Becari C; Sivieri DO; Santos CF; Moysés MK; Oliveira EB; Salgado MC
J Cardiovasc Pharmacol; 2005 Oct; 46(4):498-504. PubMed ID: 16160604
[TBL] [Abstract][Full Text] [Related]
4. Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.
Leite R; Salgado MC
Hypertension; 1992 Jun; 19(6 Pt 1):575-81. PubMed ID: 1317351
[TBL] [Abstract][Full Text] [Related]
5. Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme.
Santos CF; Caprio MA; Oliveira EB; Salgado MC; Schippers DN; Munzenmaier DH; Greene AS
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H775-83. PubMed ID: 12714330
[TBL] [Abstract][Full Text] [Related]
6. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
8. Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I.
Su J; Palen DI; Boulares H; Matrougui K
Mol Cell Biochem; 2008 Apr; 311(1-2):1-7. PubMed ID: 18084722
[TBL] [Abstract][Full Text] [Related]
9. Local formation of angiotensin II in the rat aorta: effect of endothelium.
Eglème C; Cressier F; Wood JM
Br J Pharmacol; 1990 Jun; 100(2):237-40. PubMed ID: 2198975
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
11. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of aortic smooth muscle cells and renin-angiotensin system in SHR rats.
Wang XY; Wu KG; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):136-40. PubMed ID: 10374636
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin formation in the isolated rat hindlimb.
Hilgers KF; Kuczera M; Wilhelm MJ; Wiecek A; Ritz E; Ganten D; Mann JF
J Hypertens; 1989 Oct; 7(10):789-98. PubMed ID: 2685116
[TBL] [Abstract][Full Text] [Related]
14. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Gschwend S; Henning RH; Pinto YM; de Zeeuw D; van Gilst WH; Buikema H
Br J Pharmacol; 2003 Aug; 139(7):1317-25. PubMed ID: 12890711
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the characteristics of angiotensin receptors in the renal and mesenteric vascular beds of the anesthetized cat.
Clark KL; Robertson MJ; Drew GM
J Cardiovasc Pharmacol; 1992 Apr; 19(4):515-24. PubMed ID: 1380593
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries.
Nakamaru M; Jackson EK; Inagami T
Am J Physiol; 1986 Jan; 250(1 Pt 2):H144-8. PubMed ID: 3002196
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
19. Contractile effects of tetradecapeptide renin substrate on rat femoral resistance vessels.
Juul B; Aalkjaer C; Mulvany MJ
J Hypertens Suppl; 1987 Jul; 5(2):S7-10. PubMed ID: 2443626
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin I converting enzyme (ACE)-related substances on prostacyclin generation and ACE activity of human vascular endothelial cells and rat aortic rings.
Nakagawa M; Sawada S; Uno M; Takamatsu H; Nakamura Y; Nakanishi Y; Tsuji H; Toyoda T; Sasaki S; Takeda K
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S113-5. PubMed ID: 2485042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
